Filing Details
- Accession Number:
- 0001127602-23-014093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-02 16:25:21
- Reporting Period:
- 2023-04-28
- Accepted Time:
- 2023-05-02 16:25:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741585 | Marie Johonna Pelletier | C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773 | Treasurer And Vp, Tax | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-04-28 | 2,000 | $41.93 | 4,634 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-28 | 5,400 | $59.96 | 10,034 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-28 | 5,400 | $78.76 | 15,434 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-28 | 5,100 | $97.69 | 20,534 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-04-28 | 4,800 | $122.55 | 25,334 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-28 | 1,317 | $127.06 | 24,017 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 2,000 | $126.45 | 22,017 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 5,400 | $126.43 | 16,617 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 5,400 | $126.18 | 11,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 5,100 | $126.37 | 6,117 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 4,800 | $126.33 | 1,317 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 2,000 | $0.00 | 2,000 | $41.93 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 5,400 | $0.00 | 5,400 | $59.96 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 5,400 | $0.00 | 5,400 | $78.76 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 5,100 | $0.00 | 5,100 | $97.69 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 4,800 | $0.00 | 4,800 | $122.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-03-01 | No | 4 | M | Direct | |
| 0 | 2028-03-01 | No | 4 | M | Direct | |
| 2,700 | 2029-03-01 | No | 4 | M | Direct | |
| 5,100 | 2030-03-02 | No | 4 | M | Direct | |
| 7,200 | 2031-03-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.01 to $127.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.44 to $126.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.72. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.17 to $126.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.08 to $126.47. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $126.60. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
